MYC in liver cancer: mechanisms and targeted therapy opportunities

F Liu, Z Liao, Z Zhang - Oncogene, 2023 - nature.com
MYC, a major oncogenic transcription factor, regulates target genes involved in various
pathways such as cell proliferation, metabolism and immune evasion, playing a critical role …

Glycolysis-cholesterol metabolic axis in immuno-oncology microenvironment: emerging role in immune cells and immunosuppressive signaling

J Jin, Q Zhao, Z Wei, K Chen, Y Su, X Hu, X Peng - Cell & Bioscience, 2023 - Springer
Cell proliferation and function require nutrients, energy, and biosynthesis activity to duplicate
repertoires for each daughter. It is therefore not surprising that tumor microenvironment …

[HTML][HTML] LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK …

Z Chen, L Chen, B Sun, D Liu, Y He, L Qi, G Li… - Molecular …, 2021 - Elsevier
Objective Adaptive rewiring of cancer energy metabolism has received increasing attention.
By binding with LDLs, LDLRs make most of the circulating cholesterol available for cells to …

Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling …

D Hu, RY Meng, TV Nguyen… - Molecular …, 2022 - spandidos-publications.com
Colorectal cancer (CRC) is one of the deadliest malignant tumors worldwide and its
prevalence is increasing in South Korea. The efficacy of combined treatment with natural …

[HTML][HTML] Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma

L Tang, R Wei, R Chen, G Fan, J Zhou, Z Qi… - Computational and …, 2022 - Elsevier
Hepatocellular carcinoma (HCC) represents the most important type of liver cancer, the 5-
year survival rate for advanced HCC is 2%. The heterogeneity of HCC makes previous …

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions

Q Zheng, Q Yang, J Zhou, X Gu, H Zhou, X Dong… - Cancer cell …, 2021 - Springer
Background Hepatocellular carcinoma (HCC) has a poor prognosis and has become the
sixth most common malignancy worldwide due to its high incidence. Advanced approaches …

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma

M Li, Z Wang, L Zhu, Y Shui, S Zhang… - Bioscience …, 2021 - portlandpress.com
Recent research has indicated that metabolically related genes play crucial roles in the
pathogenesis of hepatocellular carcinoma (HCC). We evaluated the associations between …

Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways

Z Zhu, J Qin, C Dong, J Yang, M Yang, J Tian… - …, 2021 - Taylor & Francis
Warburg phenomenon refers to the development of unique metabolic patterns during the
growth of tumor cells. This study stratified gastric cancer into prognostic metabolic …

Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population

R Xia, H Tang, J Shen, S Xu, Y Liang, Y Zhang… - Cancer Cell …, 2021 - Springer
Background Globally, gastrointestinal (GI) cancer is one of the most prevalent malignant
tumors. However, studies have not established glycolysis-related gene signatures that can …

Studying the mechanism underlying lipid metabolism in osteosarcoma based on transcriptomic RNA sequencing and single‐cell data

Z Li, C Jin, X Lu, Y Zhang, Y Zhang… - The Journal of Gene …, 2023 - Wiley Online Library
Background We aimed to provide a new typing method for osteosarcoma (OS) based on
single‐cell RNA sequencing (scRNA‐seq) and bulk RNA‐seq data from the perspective of …